Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-10864282-B2

Patent

Publication Date

2020-12-15

Expiration Date


Abstract

The present invention provides for a novel liquid formulation for solubilizing poorly soluble ST-246 in cyclodextrins and a novel process of making the formulation.

Core Innovation

The invention provides liquid ST-246 pharmaceutical formulations in which the poorly soluble ST-246 is solubilized using cyclodextrin. The cyclodextrin component includes hydroxypropyl-β-cyclodextrin and optionally sulfobutyl ether-β-cyclodextrin in a pharmaceutically acceptable liquid carrier, to enable oral, parenteral, mucosal, transdermal, and topical administration.

A process is described for preparing a water-soluble solid ST-246 pharmaceutical formulation by mixing ST-246 with cyclodextrin in a pharmaceutically acceptable liquid carrier, optionally filtering the mixture, and lyophilizing the resulting mixture. The formulation design includes pH adjustment and optional co-ingredients and co-solvents as described, and emphasizes solubilization and complexation behavior of ST-246 with cyclodextrin.

The disclosed content further reports solubility and complexation data comparing cyclodextrin types and formulation conditions, indicating that hydroxypropyl-β-cyclodextrin outperforms sulfobutyl ether-β-cyclodextrin in solubilization efficiency and that solubility increases with temperature and pH. Compatibility and stability are described for dilution in IV fluids, and pharmacokinetics and tolerability results are provided across mice, rabbits, and non-human primates, including comparison of IV and oral exposure characteristics.

Claims Coverage

Independent claim clm-00001 covers a process for preparing a water-soluble solid ST-246 formulation using a cyclodextrin-based liquid mixture followed by lyophilization. It includes one optional processing step and a dependent refinement identifying particular cyclodextrin variants used in the mixing step.

Mixing ST-246 with cyclodextrin in a pharmaceutically acceptable liquid carrier

Mixing ST-246 with cyclodextrin in a pharmaceutically acceptable liquid carrier.

Optionally filtering the mixture prior to lyophilization

Optionally filtering the mixture of step a).

Lyophilizing the mixture to form a water-soluble solid formulation

Lyophilizing said mixture.

Using hydroxypropyl-β-cyclodextrin and/or sulfobutyl-ether-β-cyclodextrin as cyclodextrin

Carrying out the process using hydroxypropyl-β-cyclodextrin and/or sulfobutyl-ether-β-cyclodextrin as the cyclodextrin component.

Overall, the claim coverage centers on preparing a water-soluble solid ST-246 formulation by forming a cyclodextrin-based liquid mixture and then lyophilizing it, with dependent claim refinement to hydroxypropyl-β-cyclodextrin and/or sulfobutyl-ether-β-cyclodextrin as cyclodextrin.

Stated Advantages

Solubilization of poorly soluble ST-246 using cyclodextrin in a pharmaceutically acceptable liquid carrier.

Liquid formulations enable multiple administration routes including oral, parenteral, mucosal, transdermal, and topical use.

Hydroxypropyl-β-cyclodextrin outperforms sulfobutyl ether-β-cyclodextrin in solubilization efficiency.

Compatibility and stability upon dilution with IV fluids are described.

IV formulations can yield plasma exposure characteristics comparable to oral dosing, with reported tolerability relationships to infusion rate and peak concentration.

Documented Applications

Oral administration of a cyclodextrin-based ST-246 liquid formulation.

Parenteral administration of a cyclodextrin-based ST-246 liquid formulation, including intravenous administration.

Mucosal administration of a cyclodextrin-based ST-246 liquid formulation.

Transdermal administration of a cyclodextrin-based ST-246 liquid formulation.

Topical administration of a cyclodextrin-based ST-246 liquid formulation.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.